RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 162 filers reported holding RELAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q1 2024 | $0 | – | 11 | -8.3% | 0.00% | – |
| Q4 2023 | $0 | – | 12 | +50.0% | 0.00% | – |
| Q3 2023 | $0 | – | 8 | -11.1% | 0.00% | – |
| Q2 2023 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 9 | -50.0% | 0.00% | – |
| Q4 2022 | $0 | – | 18 | +80.0% | 0.00% | – |
| Q3 2022 | $0 | – | 10 | -9.1% | 0.00% | – |
| Q2 2022 | $0 | – | 11 | -26.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 15 | -21.1% | 0.00% | -100.0% |
| Q4 2021 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |